| 000 | 01745 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516022522.0 | ||
| 264 | 0 | _c20110701 | |
| 008 | 201107s 0 0 eng d | ||
| 022 | _a1573-2509 | ||
| 024 | 7 |
_a10.1016/j.schres.2011.01.004 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHarvey, Philip D | |
| 245 | 0 | 0 |
_aPerformance and interview-based assessments of cognitive change in a randomized, double-blind comparison of lurasidone vs. ziprasidone. _h[electronic resource] |
| 260 |
_bSchizophrenia research _cApr 2011 |
||
| 300 |
_a188-94 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntipsychotic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aCognition Disorders _xdiagnosis |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterview, Psychological _xmethods |
| 650 | 0 | 4 |
_aIsoindoles _xtherapeutic use |
| 650 | 0 | 4 | _aLurasidone Hydrochloride |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPiperazines _xtherapeutic use |
| 650 | 0 | 4 | _aPsychiatric Status Rating Scales |
| 650 | 0 | 4 |
_aPsychotic Disorders _xcomplications |
| 650 | 0 | 4 |
_aSchizophrenia _xcomplications |
| 650 | 0 | 4 |
_aThiazoles _xtherapeutic use |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aOgasa, Masaaki | |
| 700 | 1 | _aCucchiaro, Josephine | |
| 700 | 1 | _aLoebel, Antony | |
| 700 | 1 | _aKeefe, Richard S E | |
| 773 | 0 |
_tSchizophrenia research _gvol. 127 _gno. 1-3 _gp. 188-94 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.schres.2011.01.004 _zAvailable from publisher's website |
| 999 |
_c20557387 _d20557387 |
||